Wang, M. Dimopoulos, M.A. Chen, C. Cibeira, M.T. Attal, M. Spencer, A. Rajkumar, S.V. Yu, Z. Olesnyckyj, M. Zeldis, J.B. Knight, R.D. Weber, D.M., Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure, Blood advances, (112), 4445-4451, 2008, American Society of Hematology,